SciELO - Scientific Electronic Library Online

 
vol.7 número1Anticonceptivo de elección post hemorragia de la primera mitad del embarazo que terminaron en aborto índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista Científica de Salud UNITEPC

versión impresa ISSN 2520-9825

Resumen

AYAVIRI, Dilean Elfy et al. Electrical cardioversion and pharmacological cardioversion in patients with atrial fibrillation. Revista UNITEPC [online]. 2020, vol.7, n.1, pp.32-42. ISSN 2520-9825.

Summary Atrial fibrillation alters the heart's hemodynamicfunction, being it a risk factor for thromboembolic accidents, complications and symptoms related with oneself cardiac arrhythmia. Restoring or preserving sinus rhythm is an important part of its management, for that two types of Restitution are established, one by an elec-tric shock and other by the use of drugs, both are valid, however there are important aspects to consider. The work objective is to compare the characteristics and indications for the use of electrical and pharmacological cardioversion in patients with atrial fibrillation. A comparison was made between both considering the characteristics of each method, techniques, mechanism, im-portant points to take into account, indications, complications and effectiveness. The right patient choice and a proper technique is significant to restore a normal heart rhythm. Both have specific characteristics and limitations. At the acting moment, there is no procedure that can be considered optimal, sometimes it is necessary to resort to a combined strategy. It has been noticed that the prescription of antiarrhythmic drugs before an electrical cardioversion can be useful to increase success and prevent it.

Palabras clave : Atrial Fibrillation; Electric Countershock; Anti-Arrhythmia Agents; Throm-boembolism; Heart Failure.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons